- Journalists Discuss Healthcare Costs’ Political Fallout, Concerns About Canceled ICE Facility
- Missouri hospital names interim chief administrative officer
- OSF taps foundation president
- Morgan Medical Center launches cardiology service line in Georgia
- The hospitals, health systems cutting jobs in 2026
- Nevada expands Medicaid dental benefits for adults
- 2 dead in Missouri hospital shooting
- New Mexico dentist fined $320K for violating Controlled Substances Act
- Ketamine: 5 notes for behavioral health leaders
- 60 statistics on hospital expenses in mid-2026
- Judge dismisses Stryker cyberattack lawsuit; plaintiffs could refile
- 42 hospitals closing departments or ending services
- Oklahoma surgeon completes world’s 1st knee procedures with Lantern ASC system
- The colonoscopy reimbursement cut GI ASCs didn’t see coming
- Aspen Dental to open Alabama office
- Anthropic’s biggest healthcare bets: 6 key moves
- Mental health admissions averaged $15.9K in total costs: 5 things to know
- DSOs target de novo practices: 7 updates
- 50+ dental executives on the move in the 1st half of 2026
- Gender ratio of nurse practitioners across 50 states
- Palomar Health, UC San Diego Health finalize JPA, form new system
- 6 DSOs making headlines
- 7 new psychiatric residency programs to know
- The ASC cost crisis, by specialty
- US Heart and Vascular expands network with 2 cardiology practice partnerships
- The states losing anesthesiology residents fastest
- 5 mergers, acquisitions in June
- South Carolina behavioral health agency cuts 47 filled positions
- U of Rochester Medical center taps GI surgery chief
- DEA moves to schedule synthetic kratom compound
- The newest weapon against insurer nonpayment — and its growing controversy
- CMS wants power to remove ‘problematic’ physicians, ASCs from Medicare
- Physician practice owner to pay $1.5M to resolve false claims allegations
- 5 DSOs that dominated Q2
- FDA Lets 20 ZYN Nicotine Pouches Claim Lower Risk Than Cigarettes; Critics Warn Of Danger
- Ultra-Processed Foods Linked To Brain Differences In Young Children
- Prompt Responses From Mom Might Lower A Baby's Risk Of Childhood Mental Health Problems
- Rehab Program Helps Lift Long COVID 'Brain Fog'
- Why Are You Right- Or Left-Handed? Experiments Suggest Surprisingly Simple Explanation
- Rural Americans More Likely To View Cancer As A Death Sentence, Poll Finds
- He Dreamed Of Becoming A Physician Assistant. New Loan Rules May Thwart Him.
- New Disease Threats Follow Trump Administration’s Health Program Cuts
- HealthQ Special: Caregiving in the Sandwich Generation
- A Mom Said Infant Formula Killed Her Baby. The Manufacturer Closed the File.
- Author Health expands mental health, dementia care services
- PDS Health opened 5 de novo offices in June
- Heartland Dental added 6 de novo offices in June
- California’s school behavioral health reimbursement program stalls
- CMS mulls tougher Medicare enrollment rules to combat fraud as part of 2027 home health payment rule
- Tenpoint debuts cast of lively everyday objects to zoom in on blurry vision hassles in Yuvezzi ad
- CMS goes live with GLP-1 Bridge program for Part D beneficiaries
- New Connecticut law expands Yale psychedelic-assisted therapy pilot
- The missing piece in crisis care? A model that avoided 1,580 ED days
- FDA Scientists Warn Against Expanded Peptide Access As Kennedy Reshapes Advisory Panel
- Lonza expands partnership with US drugmaker, boosts capacity for ADCs
- Trump administration withholds funds from New York's Medicaid fraud unit
- Alcohol accounts for 74% of substance use inpatient stays: 4 things to know
- Sanofi unit in Ireland chided by FDA over manufacturing flubs linked to Altuviiio
- Regulatory tracker: FDA sets decision date for Sarepta's DMD drugs
- Can A Popular Muscle Supplement Help Treat Depression?
- Zelis rolls out AI solution to help payers navigate No Surprises Act dispute process
- BridgeBio attracts $1B in equity for new launches, but analyst smells M&A ‘dry powder’
- Melatonin Shows Promise As Safe, Cheap Painkiller, Review Concludes
- Heat Dome Coming: Tips To Stay Safe During Extreme Temps
- Diets That Lower Inflammation Might Cut Dementia Risk, Study Indicates
- Vitamins Might Be Key To Asthma Control In Children, Adults
- Kimball lays out $103M to bolster life sciences CDMO footprint across Europe, India
- Haleon teams up with Microsoft in 5-year AI pact to upgrade consumer health operations
- ACCESS Model: behavioral health edition
- Would Hunters Take A Lyme Disease Vaccine? We Asked
- Affordable Healthcare Emerges as a Voter Priority in Purple Nevada
- Newsom Vowed To Transform Kids’ Mental Health. Many California Schools Are Still Waiting.
- Plus Therapeutics rebrands as Cerenome as it deepens AI strategy
- Orca Bio makes a splash with FDA approval for cell therapy Tregzi. Could an IPO come next?
- Remarks at the Economic Club of New York
- Evernorth unveils new AI-powered specialty pharmacy program, Pharmacy Forward
- 26 states sue CMS over final Medicaid work requirements rule
- Startup Queue lands $12.6M to launch autonomous robotic pharmacy kiosks
- Carbon Health agrees to revise contracts with its California clinics, pay penalties
- Experity acquires Exdion Healthcare to accelerate on-demand care RCM automation
- AstraZeneca agrees to pay $34M to settle 'free nurses' kickback lawsuit from Texas
- From Caffeine To 'Healthy' Labeling, FDA Sets Year-End Agenda For US Food Supply
- A 40-Year-Old Law Requires ERs To Treat Everyone — Unless They Opt Out
- Major Study Supports Same-Day COVID-19 and Flu Vaccination
- American Hospital Association names Steve Walsh as next CEO
- Medical journal retracts Tavneos pivotal study article, complicating Amgen’s defense effort
- Hyro rolls out analytics platform to glean insights from AI agent interactions
- Women With Parkinson's More Likely To Have Brain Changes Related To Alzheimer's
- Even Mild Weather Changes Impact Mental Health
- Breastfeeding Might Lower ADHD Risk, Study Finds
- After monotherapy failure, AbbVie and Genmab tout Epkinly combo win in DLBCL
- FDA selects Lilly, Regeneron, Fujifilm, 4 others for PreCheck Pilot Program
- She Struggled To Get A Lifesaving Drug Even After Insurers Vowed To Help
- Trouble Getting Weight Loss Drugs Covered By Insurance? Here's What To Know
- Would Hunters Take a Lyme Disease Vaccine? We Asked
- These Church Members Disagree on Politics. Together They’re Wiping Out Medical Debt.
- He Dreamed of Becoming a Physician Assistant. New Loan Rules May Thwart Him.
- Unicycive turned away by FDA again over manufacturer’s plant shortfalls
- Roche tops oncology reputation rankings as AstraZeneca climbs back to 2nd place
- Rising Stars: How Novo Nordisk’s Tara Sparks Went from Super Bowl Fan to Super Bowl Marketer
- Rural residents falling behind urban and suburban communities on medical, cancer screenings
- CMI Media Group bridges gaps in pharma marketing tech with newly launched Ad Astra platform
- How payers, drugmakers can collaborate to drive more outcomes-based contracts
- BeOne’s Brukinsa hits goal in mantle cell lymphoma confirmatory trial
- HRSA opens applications for $140M in rural health grant funding
- ACA marketplace enrollment down by 3M as of February, new federal data show
- Cases Of Rare But Dangerous Powassan Tick Virus Rising In U.S.
- Nearly 3 in 10 Young Adults Don't Have a Regular Doctor, Survey Finds
- Clinic network CEO pleads guilty to embezzling millions for 'social media influenced' market trading
- AI playing a major role in consumers' healthcare decision-making, survey finds
- Zymeworks acquires struggling Theravance for $929M
- Is Your Organization Ready to Govern AI in Regulatory Affairs?
- Klick bags Oxford PharmaGenesis in 3rd takeover in 18 months
- FDA rejects Sobi’s gout drug over manufacturing issues, sparing Amgen blockbuster
- Fertility Preservation Often Overlooked In Women's Cancer Care, Review Finds
- Sedatives Pose Fall Hazard For Recently Hospitalized Seniors
- Fourth Of July Poses Burn Hazards — Here's How To Protect Kids
- Efforts To End School Vaccine Mandates Hit A Wall In Florida
- A Dog's Stride Could Be An Early Sign Of Dementia, Study Says
- Florida Hospitals Act Fast To Discharge Gun Victims — Especially if They’re Not Insured
- Look out, Amgen. Here comes Viridian with FDA nod for TED med Lumvoa
- Doctronic, Simple HealthKit partner to connect at-home screening with AI-powered clinical care
- HHS announces new oversight measures for TEFCA, touts 1B health records exchanged
- Cancer Drug Shortage Renews Calls For Federal Action
- 3 in 10 adults turn to AI or social media for health advice, citing difficulties accessing and affording care
- Next-Generation Blood Test Improves Detection Of Aggressive Prostate Cancer
- Saint Peter’s Healthcare System Expands Intelligent Hospital Room Initiative with hellocare.ai to Advance AI Assisted Patient Safety and Virtual Care
- As PBM industry shifts, LucyRx and Abarca Health merge to build scale
- One Brooklyn Health Selects hellocare.ai to Advance AI-Powered Virtual Care Across Its Hospitals
- Most Patients Want Docs To Break Cancer News Directly, Not Through Portal Messaging
- Statins Rarely Cause Severe Muscle Problems, Researchers Say
- Even In Blue States, Hospitals Continue To Drop Gender-Affirming Care For Youths
- Younger U.S. Generations Increasingly Fear Adulthood, Study Says
- Opioid Settlement Money Pays For Services To Battle Addiction In Rural Kentucky
- Air Force Outbreak Grows As Military Reinstates Flu-Shot Rule For Recruits
- GLP-1 Weight-Loss Boom Linked To Surge In Poison Control Calls
- Brain Scans Improve Targeting Of Magnetic Stimulation For Depression
- Estrogen Birth Control May Protect Women’s Brains As They Age
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
- Statement on the Proposed Amendments to Regulation NMS
- This Old House: Improving and Remodeling Our Registered Offering and Filer Status Regimes
- Peirce Out: Remarks at the U.S. Chamber of Commerce Capital Markets Summit
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- “Harmonization: We’ll Have Lots to Talk About”
Michigan healthcare freedom community forum
Michigan's official vaccine stance was never in doubt, but those who like details will enjoy today's MDHHS Press Release.
I've highlighted the core argument in bold font.
https://www.michigan.gov/mdhhs/inside-mdhhs/newsroom/2025/09/19/standing-rec
State’s Chief Medical Executive Dr. Natasha Bagdasarian makes Standing Recommendation on COVID-19 vaccines
Determines not receiving a dose of COVID-19 vaccine to be an underlying conditionLANSING, Mich. - In response to Gov. Gretchen Whitmer’s Executive Directive to state agencies to ensure Michigan families can access COVID-19 vaccines, the state’s Chief Medical Executive Dr. Natasha Bagdasarian has issued a Standing Recommendation for the COVID-19 vaccine.
“National medical organizations and scientific experts continue to recommend routine COVID-19 vaccination for those at high risk, but also recommend vaccines be made available for all those who want them, ages six months and older,” said Bagdasarian. “COVID-19 vaccines have been proven to reduce the likelihood of emergency department or urgent care visits, as well as hospitalizations and severe outcomes. They are one of our best defenses against the virus. As the state’s chief medical executive, it is my duty to protect and promote public health, and everyone deserves the opportunity to access COVID-19 vaccine if they desire one. This Standing Recommendation will help to protect vaccine accessibility and availability in our state.”
On Wednesday, Aug. 27, the U.S. Food and Drug Administration (FDA) approved the 2025-2026 vaccine for those 65 years of age and older and those ages 5 through 64 years with at least one underlying condition that puts them at high risk for severe outcomes from COVID-19. However, the FDA did not define the list of underlying conditions. The Centers for Disease Control and Prevention’s list includes conditions such as obesity and physical inactivity and states it is “not exhaustive” and “should not be used to exclude people with underlying conditions from recommended measures for prevention or treatment of COVID-19.”
In her recommendation, Bagdasarian stated, “Any person over the age of six months without contraindication who has not received a dose of a Food and Drug Administration (FDA)-approved or -authorized 2025-2026 COVID-19 vaccine may be considered to have an underlying condition that puts them at high risk for severe outcomes from COVID-19 and is thus eligible to receive an age-appropriate dose.”
The Michigan Department of Health and Human Services (MDHHS) continues to recommend the COVID-19 vaccine in alignment with the American Academy of Pediatrics, the American Academy of Family Physicians, and the American College of Obstetricians and Gynecologists.
To help ensure insurance coverage and availability of COVID-19 vaccines as outlined in the Executive Directive, MDHHS is working with the Department of Insurance and Financial Services and the Michigan Department of Licensing and Regulatory Affairs.
To learn more about COVID-19 and seasonal respiratory illnesses and how to protect yourself, visit Michigan.gov/COVIDFluRSV.
# # #
In the game of governments and vaccine policy, looks like the ball is back in the Trump Administration's court. Any bets on Medicaid funding playing a major role?
LARA just issued the same presser under the subject line, "Sharing on behalf of MDHHS."
No other comment, but an early signal to every licensed health professional in Michigan that compliance is expected.
Also Friday, the CDC's recommendation changed.
My favorite part: "shared clinical decision-making." ❤️ 🥂
Close second: MedPage again referencing "pregnant women." 😊
https://www.medpagetoday.com/infectiousdisease/covid19vaccine/117567
CDC Panel Stops Endorsing COVID Shots, Pushes for 'Choice'
— RFK Jr.'s committee breaks from flu shot model, leaves it up to individuals to decide
by Terrence Rudd, Staff Writer, MedPage Today
September 19, 2025The CDC's vaccine advisory committee is no longer recommending the COVID-19 shot for specific groups of Americans, but instead stressing shared clinical decision-making in its newest recommendations.
The Advisory Committee on Immunization Practices (ACIP) on Friday unanimously voted 12-0 to update its recommendations for pediatric and adult immunization schedules, but it deviated from recent FDA vaccine approval language by simply calling for "individual-based decision-making" in everyone ages 6 months and older.
For those 6 months to 64 years, this was paired with recommended language that added "an emphasis that the risk-benefit of vaccination is most favorable for individuals who are at an increased risk for severe COVID-19 disease and lowest for individuals who are not at an increased risk, according to the CDC list of COVID-19 risk factors."
Until now, the vaccinations had been recommended as a routine step in the fall for nearly all Americans who wanted them -- just like a yearly flu vaccine.
Not everything earned unanimous support during the meeting. A motion to recommend that prescriptions be required to get a COVID vaccine led to a deadlocked 6-6 vote, with ACIP Chair Martin Kulldorff, PhD, formerly of Harvard Medical School in Boston, using his tie-breaking power to kill the proposal.
Panelists worried that the prescription proposal could cut pharmacists -- who administer more than 90% of all COVID shots but can't write prescriptions under Medicare Part B rules -- from the ranks of vaccination providers. The effects could slash access and clog primary care providers' offices, some members cautioned.
A third motion to strengthen discussions with patients about COVID vaccination risks and benefits also earned unanimous 12-0 approval. That recommendation calls for discussion of known risk factors for severe COVID outcomes, including age, prior infections, immunosuppression, and other comorbidities identified by the CDC, as well as "a discussion of the potential benefits and risks of vaccination and related uncertainties, especially those outlined in the vaccine information statement, as part of informed consent."
A fourth recommendation encouraged the CDC to promote more consistent, comprehensive informed consent processes, and to encourage the addition of descriptions of six risks and uncertainties outlined by ACIP member and COVID-19 working group chair Retsef Levi, PhD, of the Massachusetts Institute of Technology Sloan School of Management in Boston. That motion passed on an 11-1 vote.
Kulldorff emphasized that the vaccination schedule recommendations won't affect vaccine access in the Vaccines for Children Program -- the federally run program that covers vaccines for about half of children in the U.S.
Sean O'Leary, MD, of the American Academy of Pediatrics (AAP), said the panel's daylong debate involved clear efforts to "sow distrust" about vaccines and would have "real-time impacts on American children."
But he expressed relief that people could instead follow guidelines from his and other medical groups that still recommend the vaccines be available, like in prior years.
"It was a very, very strange meeting," O'Leary said.
A Festivus of Vaccine Uncertainties
In June, HHS Secretary Robert F. Kennedy Jr. sacked the 17 former members of ACIP and replaced them with members more aligned with his views. During the meeting, new members put plenty of focus on COVID vaccines' perceived unknown risks and uncertain benefits.
The discussion featured contentious topics including alleged DNA alterations by mRNA vaccines and case reports of myocarditis in vaccinated people, assertions that mRNA vaccines don't work as intended, the existence of a post-vaccination syndrome, and potential connections between the vaccines and conditions such as birth defects and cancer.
In a presentation to the panel, CDC COVID-19 workgroup member Henry Bernstein, DO, of the Zucker School of Medicine at Hofstra/Northwell in New York, delivered a stinging dissent to the panel's skeptical tone. The former ACIP member called for continued vaccination coverage for a wide range of populations, including pregnant women, children younger than 2 years, older adults, "and anyone who feels they want protection for themselves and their families."
"If we don't want to say vaccines are 'safe and effective,' well, they work!" Bernstein said.
ACIP, FDA, and Medical Organizations Sing Separate Tunes
Last month, the FDA approved updated COVID vaccines for the 2025-2026 respiratory virus season for all adults 65 and older, but limited their use in younger people and children to those with at least one condition that puts them at high risk for severe disease. Kennedy also announced in May that the CDC had dropped its recommendationopens in a new tab or window that healthy children and pregnant women get routine COVID shots.
Those moves prompted multiple medical organizations to issue their own vaccination recommendations, including the AAP, the American College of Obstetricians and Gynecologists (ACOG), the American Academy of Family Physicians (AAFP), and the Society for Maternal-Fetal Medicine (SMFM). The AAP and AAFP said that all children ages 6 to 23 months should be vaccinated against COVID. ACOG, SMFM, and AAFP also recommended that women who are pregnant at any stage or lactating should get a COVID shot.
Health insurer industry group AHIP released a statement Tuesday that backs ACIP's older, broader COVID vaccination recommendations. "Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing for patients through the end of 2026," AHIP said.
On Friday, the Infectious Diseases Society of America (IDSA) again called for Kennedy to resign.
"His leadership has already put up barriers to many Americans' choice to receive the COVID vaccine," said IDSA President Tina Tan, MD, in a statement. "Now he is attacking routine childhood vaccines that have been given broadly and safely for decades, creating chaos and confusion, taking away parents' choices and putting children's lives at significant risk for severe vaccine-preventable diseases."
Typically, ACIP recommendations must be approved by the CDC director, and are not considered final until they are published in the Morbidity and Mortality Weekly Report.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.






















